期刊
REVISTA BRASILEIRA DE PSIQUIATRIA
卷 29, 期 -, 页码 S41-S47出版社
ASSOC BRASILEIRA PSIQUIATRIA
DOI: 10.1590/S1516-44462007000600002
关键词
schizophrenia/therapy; drug utilization review; clinical protocols; pharmacologic actions; treatment outcome
类别
Objective: The aim of the present paper is to review the various aspects of refractory schizophrenia regarding issues such as definitions, clinical aspects, psychobiological correlates, pharmacological and non-pharmacological treatment options and predictors of treatment response. Method: Medline search as well as articles of the authors. Results and Conclusions: Refractory schizophrenia affects at least one third of patients with schizophrenia and the best evidence shows that is monotherapy with clozapine remains the mainstay for the treatment of such condition. Antipsychotic polipharmacy is not supported by current evidence and recent clinical trials have shown that clozapine augmentation with antipsychotics has no benefit over placebo.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据